Results 211 to 220 of about 5,099,009 (221)

A phase II study of bortezomib in mantle cell lymphoma: the National Cancer Institute of Canada Clinical Trials Group trial IND.150

Annals of Oncology, 2007
Randy D Gascoyne, M Crump, A Belch
exaly  

Autologous stem-cell transplantation in patients with mantle cell lymphoma beyond 65 years of age: a study from the European Group for Blood and Marrow Transplantation (EBMT)

Annals of Oncology, 2012
Anna Sureda, P W Wijermans, Pierre Biron
exaly  

Oral arsenic trioxide-based regimen as salvage treatment for relapsed or refractory mantle cell lymphoma

Annals of Oncology, 2014
Harinder Gill, W Y Au, Y L Kwong
exaly  

Outcome and prognostic factors in patients with mantle-cell lymphoma relapsing after autologous stem-cell transplantation: a retrospective study of the European Group for Blood and Marrow Transplantation (EBMT)†

Annals of Oncology, 2014
José Luis Díez-Martín, G Kobbe, A Boumendil   +2 more
exaly  

Rituximab consolidation after high-dose chemotherapy and autologous blood stem cell transplantation in follicular and mantle cell lymphoma: a prospective, multicenter phase II study

Annals of Oncology, 2004
G Schlimok, P Brossart, Roland Repp
exaly  

Phase I trial of rituximab, cladribine, and temsirolimus (RCT) for initial therapy of mantle cell lymphoma

Annals of Oncology, 2014
Thomas E. Witzig, D J Inwards, B R Laplant   +2 more
exaly  

Biclonal mantle cell lymphoma

Blood
Preetesh Jain, Fatima Zahra Jelloul
openaire   +2 more sources

Early-stage mantle cell lymphoma: a retrospective analysis from the International Lymphoma Radiation Oncology Group (ILROG)

Annals of Oncology, 2017
R T Hoppe, A K Ng, S A Terezakis
exaly  

Intensive treatment strategies may not provide superior outcomes in mantle cell lymphoma: overall survival exceeding 7 years with standard therapies

Annals of Oncology, 2008
R Niesvizky, J P Leonard, P Christos
exaly  

Reduced-intensity conditioning allogeneic stem cell transplantation for relapsed/refractory mantle cell lymphoma: a multicenter experience

Annals of Oncology, 2012
Nicolaus Kröger, Sunday Ocheni, Arnon Nagler   +2 more
exaly